Radiotherapy is a frontline treatment for the clinical management of CNS tumors. Although effective in eradicating tumor cells, radiotherapy also depletes neural stem and progenitor cells in the hippocampus that are important for neurogenesis and cognitive function. Consequently, the use of radiation to control primary and metastatic brain tumors often leads to debilitating and progressive cognitive decrements in surviving patients, representing a serious medical condition that, to date, has no satisfactory, long-term solutions. As a result, we have explored the use of stem cells as therapeutic agents to improve cognition after radiotherapy. Our past work has demonstrated the capability of cranially transplanted human embryonic (hESCs) and neural (hNSCs) stem cells to functionally restore cognition in rats 1 and 4 months after head-only irradiation. We have now expanded our cognitive analyses with hESCs and quantified both survival and differentiated fates of engrafted cells at 1 and 4 months after irradiation. Our findings indicate the capability of hESC transplantation to ameliorate radiation-induced cognitive dysfunction 1 month following cranial irradiation, using a hippocampal-dependent novel place recognition task. Irradiated animals not engrafted with stem cells experienced prolonged and significant cognitive dysfunction. Stereological estimates indicated that 35% and 17% of the transplanted hESCs survived at 1 and 4 months postgrafting, respectively. One month after irradiation and grafting, phenotypic analyses revealed that 26% and 31% of the hESCs differentiated into neurons and astrocytes, while at the 4-month time, neuronal and astrocytic differentiation was 7% and 46%, respectively. Comparison between present and past data with hESCs and hNSCs demonstrates equivalent cognitive restoration and a preference of hNSCs to commit to neuronal versus astrocytic lineages over extended engraftment times. Our data demonstrate the functional utility of human stem cell replacement strategies for ameliorating the adverse effects of cranial irradiation on cognition.
INTRODUCTION
Radiotherapy provides the most effective means for forestalling the progression of primary and secondary malignancies in the brain. While beneficial, cranial irradiation causes an unintended and deleterious decline in cognitive function in cancer survivors, representing a significant clinical problem that remains unresolved with no long-term, satisfactory solutions (1, 8) . Pediatric cases are a particular concern, as their longer-term survival is with marked cognitive decrements that severely impact quality of life and impose significant socioeconomic burdens (22, 31) . Despite treatments designed to limit overt morphologic brain injury, variable degrees of cognitive dysfunction that manifest as impaired hippocampaldependent (and independent) learning and memory occur routinely and persist, and can include disrupted attention and concentration and impaired executive functions such as planning and multitasking (20, (28) (29) (30) . Thus, although advancements in cancer treatment have led to prolonged survival, similar improvements to long-term cognitive function have not been realized.
The mechanisms underlying radiation-induced cognitive dysfunction are complex, but accumulating evidence now indicates that disruption to hippocampal neurogenesis plays a contributory, if not causal, role (20, 36) . Ionizing radiation depletes radiosensitive populations of multipotent neural stem and progenitor cells in the hippocampus and elicits a persistent oxidative stress that compromises the neurogenic niche and serves to impair neurogenesis long after irradiation (6, 14, (19) (20) (21) . The temporal time course of stem cell death, the inhibition of neurogenesis, and the onset of hippocampal-dependent learning and memory have suggested the importance of neural stem cells and neurogenesis in the maintenance of cognitive function throughout life (20, 21) . Such evidence also implies that strategies directed at preserving and/or replenishing stem cell pools in the brain may forestall the development of cognitive impairments that plague those surviving the treatment of brain cancer.
To explore interventions that might provide some clinical recourse to those afflicted with radiation-induced cognitive dysfunction, we have developed an animal model in which we have conducted intrahippocampal transplantation of human stem cells following cranial irradiation (2,3). Our prior work has now established the efficacy of this methodology, whereby human embryonic (hESCs) or neural (hNSCs) stem cells transplanted 2 days after headonly irradiation were found to survive, differentiate along neuronal and glial lineages, and ameliorate impairments in cognition as long as 1 and 4 months afterward (2-5). To more completely understand the potential limitations and the underlying mechanisms responsible for the beneficial effects of cranially transplanted stem cells, we have expanded on our studies using hESC significantly. Here, we report our findings that hESC transplantation improves cognition at earlier as well as later times postengraftment, along with the quantified yields of engrafted cell survival and differentiated fate 1 and 4 months later. We also compare the functional consequences and outcomes of transplanted human stem cells in the irradiated brain.
MATERIALS AND METHODS

Animals and Irradiation
All animal procedures were performed in accordance with US National Institutes of Health (NIH) and Institutional Animal Care and Use Committee (IACUC) guidelines. As in our previous study (2,3), we employed immunocompromised athymic nude rats (ATN) to circumvent cross-species immune rejection. A total of 38 young (2-month-old), male ATN rats (strain 02N01 Cr:NIH-rnu; NCI), maintained under sterile conditions, were used in this study. Animal groups included nonirradiated sham surgery controls (CON; 1-month and 4-month, n = 8), irradiated sham surgery (IRR; 1-month, n = 6; 4-month, n = 12), and irradiated with engrafted hESCs (IRR + hESC; 1-month, n = 6; 4-month, n = 6). Anesthetized rats were exposed to cranial g-irradiation (10 Gy) using a 137 Cs irradiator (Mark I, J. L. Shepard and Associates, Glendale, CA) at a dose rate of 2.07 Gy/min, as previously described (2,3).
Human Stem Cell (hESC and hNSC) Transplantation Surgery
The use of human stem cells in this study was approved by UCI's Human Stem Cell Research Oversight Committee (hSCRO). The hESC line H9 (a kind gift from Dr. Peter J. Donovan, UC Irvine) was maintained as monolayer colonies (passages 42-49), as described previously (2). Prior to transplantation, undifferentiated hESCs were labeled with 5-bromo-2¢-deoxyuridine (BrdU; Sigma-Aldrich), and BrdU incorporation was detected using immunocytochemistry according to a standard protocol (2,3). The in vitro BrdU index for all transplantation studies was 98 ± 0.75 (mean ± SEM, n = 16). The data for hNSCs (ENStem-A cell line, EMD Millipore) described in our previous study (3) have been adapted and replotted for comparison with our new hESC data presented in this study.
Irradiated rats received bilateral, intrahippocampal engraftment of BrdU-labeled hESCs 2 days after cranial irradiation (IRR + hESC). Live undifferentiated hESCs (1.0 × 10 5 ) were injected per grafting site in 1 µl of the cell suspension using a 33-gauge microsyringe at an injection rate of 0.25 µl/min. Each hippocampus received four distinct injections (total 4.0 × 10 5 live hESCs per hemisphere) using the following stereotaxic coordinates (2): (i) AP: 3.0 mm from bregma, ML: 1.8 mm from midline, and ventral DV: 3.2 mm from the surface of the brain; (ii) AP: 3.6 mm, ML: 2.5 mm, DV: 3.2 mm; (iii) AP: 4.2 mm, ML: 3.2 mm, DV: 3.2 mm; and (iv) AP: 4.8 mm, ML: 4.0 mm, DV: 3.2 mm. Control (CON) and irradiated (IRR) rats receiving sterile vehicle (conditioned medium) at the same stereotaxic coordinates served as sham surgery groups.
Assessment of Cognition
CON, IRR, and IRR + hESCs groups were tested on a novel place recognition (NPR) task at 1 or 4 months postgrafting. The NPR task uses spontaneous exploration as a means of assessing spatial recognition memory, which relies on intact hippocampal function (23, 32) . A standard protocol (2,3) was followed employing Ethovision XT software (v6.0, Noldus Information Technology, Inc., Leesburg, VA) for automated tracking and exploration detection. Two open-field white acrylic arenas, each measuring 45 high × 70 × 70 cm were placed next to each other on the floor of a brightly lit, dedicated behavioral testing room. Various large, high-contrast posters placed on the walls of the testing rooms served as extramaze spatial cues. The task began with 2 days of habituation, during which rats explored the arenas and two toy objects that were not used for subsequent testing for 20 min before being returned to their home cages. For all phases, arenas and objects were cleaned with 70% ethanol between trials to minimize odor cues. The familiarization phase and 5-min test phase were administered the following day. Identical plastic blocks (~8 × 3 × 10 cm high), placed 27 cm from opposing corners of the arena, were used as stimuli. Small pieces of white Velcro placed on the undersides of the blocks were used to secure them in place during testing. For the familiarization phase, rats were placed in the arenas to explore for 5 min and then returned to a holding cage for a 5-min retention interval. For the 5-min test phase, one of the stimuli was moved to an open corner at a distance of 18 cm from the arena wall ("novel place"), while the other block remained at its former spatial location ("familiar place"), and rats were returned to the arenas for 3 min. Rats were then returned to their home cages for a delay of 24 h before being returned to the arenas for the 24-h test phase. For this phase, the "novel place" block was again moved, this time to the remaining open corner, and the "familiar place" block remained in the same location. For all phases, the "head direction to zone" function in Ethovision XT was used to track exploration of the blocks. Exploration was defined as the animal's head being directed toward and located within a 2-cm radius of the stimulus.
Immunohistochemistry, Stereology, and Confocal Microscopy
At the end of behavior testing, animals were euthanized by intracardiac perfusion and tissues were processed as described (2). For stereological quantification, every 10th section through the entire hippocampus was processed for BrdU immunostaining (3). Stereological counting of BrdU-positive nuclei was done using an Olympus BX60 microscope (MBF CX9000 color digital camera and 100× oil immersion lens with 1.30 numerical aperture), three-axis motorized stage, and StereoInvestigator software (v9.0, MBF Biosciences, Williston, VT) using unbiased stereological principles, as described previously (3). The surviving hESCs are reported as the percentage yield of graft-derived cells at 1 and 4 months postgrafting and compared to our previous data with hNSCs (3). The Guenderson coefficient of error (CE) for each hippocampus was <0.038 ± 0.0025 (mean ± SEM, n = 8).
Phenotypic fate analysis of hESC graft-derived cells was done using dual-immunofluorescence and laser scanning confocal microscopy (Nikon Eclipse TE2000-U, EZ-C1 interface) as described previously (2,3). Standard immunostaining protocols were used for BrdU (Millipore) and neuronal [neuron-specific class III b-tubulin (antibody: Tuj1; Covance), neuronal nuclei (NeuN; Millipore)], astroglial [glial fibrillary acidic protein (GFAP; Invitrogen), S100 calcium binding protein (S100; Millipore), oligodendrocyte marker O4 (O4; Millipore), chondroitin sulfate proteoglycan 4 (NG2; Millipore)], and functional markers (Ki67 and nestin; both from Millipore) as described in detail previously (2,3). Z-stack analyses were carried out using 1-µm stack intervals, and orthogonal image reconstruction was done using Nikon Elements AR software (v3.2, Nikon Instech Co. Ltd., Japan).
Statistical Analyses
Exploration ratio, or the proportion of total time spent exploring the novel spatial location (t novel / t novel + t familiar ), was used as the main dependent measure for statistical analyses.
We analyzed the behavior of the animals during minute 1 of the 5-min and 24-h test phases; previous research has shown that preference for the novel place diminishes after the first minute as the spatial locations become equally familiar to the animals (23). To establish baseline exploratory behavior, we also analyzed exploration of the stimuli during the initial familiarization phase.
Analyses of cognitive data were performed using PASW Statistics version 17.0 (SPSS Inc.). Analyses for the 1-and 4-month posttransplantation times were conducted separately. Group sample sizes for the statistical analyses were as follows: nonirradiated sham surgery controls (CON; 1-month and 4-month, n = 8), irradiated sham surgery (IRR; 1-month, n = 6; 4-month, n = 12), and irradiated with engrafted hNSCs (IRR + hNSC; 1-month, n = 6; 4-month, n = 6). In all cases, statistical tests were two-tailed, and values of p < 0.05 were considered statistically significant.
Exploration ratio data were analyzed using univariate ANOVAs for the 5-min and 24-h test phases. In all cases, we confirmed that the data were normally distributed using the Kolmogorov-Smirnov test and that the error variances did not differ between groups by using Levene's test of equality of error variances. When a statistically significant overall group effect was found, multiple comparisons were made using Fisher's protected least significant difference (FPLSD) post hoc tests to compare the individual groups. Additional analyses of recognition memory were conducted using one-sample t tests to determine if the mean proportion of time spent exploring the novel spatial location for each group differed significantly from chance (i.e., 0.05).
RESULTS
HESC Grafting Improves Cognition
One month postgrafting, rats were habituated and trained on the NPR task. Successful performance of the task has been shown to rely on intact hippocampal function (23,32). As we have demonstrated in past studies (2,3), irradiated rats (IRR) showed impaired novel place recognition at the short, 5-min retention interval. The group means and 95% CI for the 5-min test were as follows: CON (mean, 0.7812; 95% CI, 0.5174-1.0451), IRR (mean, 0.0717; 95% CI, -0.0641-0.2074), and IRR + hESC (mean, 0.6150; 95% CI, 0.1097-1.1203). We found significant group differences for exploration ratio at the 5-min retention interval ( Fig. 1A) [F(2,17) = 7.912; p = 0.004]. Irradiated animals spent significantly less time exploring the novel place compared to both CON (p < 0.001) and IRR + hESC (p = 0.013). Moreover, IRR animals explored the novel place less than expected by chance (p = 0.001). In contrast, after the 5-min retention interval, irradiated, hESC-transplanted rats (IRR + hESC) did not differ from CON animals and, like controls, spent more time than (A, C) Exploration ratios (i.e., t novel / t novel + t familiar ) for the first minute of the 5-min and 24-h test sessions, respectively. (A) Following the 5-min retention interval, irradiated animals (IRR) spent a significantly lower proportion of time exploring the novel place versus controls (Con; p = 0.001) and transplanted animals (IRR + hESC; p = 0.013). In contrast, irradiated animals that received hESC injections (IRR + hESC) did not differ from controls (p = 0.375). (C) After the 24-h retention interval, animals in the IRR group spent a lower proportion of time exploring the novel place, although this difference was not statistically significant. IRR + hESC animals showed a trend toward improved performance compared to the IRR cohort and spent more time than expected by chance exploring the novel spatial location (p = 0.045). Similar trends were observed when total time spent exploring the novel place was assessed after both the 5-min (B) and 24-h (D) retention intervals. Analysis of time spent exploring both objects during the initial familiarization phase revealed no significant group differences, although IRR animals tended to spend less time engaged in exploration than both the Con and IRR + hESC groups (E). expected by chance exploring the novel spatial location (indicated by the dashed line in Fig. 1A) . Analogous trends were observed in terms of total time spent exploring the novel spatial location (Fig. 1B) and frequency of visits to the novel spatial location and latency to explore the novel spatial location (data not shown). These results suggest that transplantation of hESC ameliorated postirradiation cognitive impairments and preserved short-term memory for spatial information in a hippocampal-dependent task up to 1 month later.
At the 24-h retention interval, IRR rats again exhibited impaired NPR compared to control animals (Fig. 1C ). As before, IRR + hESC rats did not differ significantly from CON animals and spent more time than expected by chance exploring the novel spatial location (p = 0.045) (Fig. 1C ). For this longer retention interval, the irradiated group transplanted with stem cells (IRR + hESC) also showed a trend for increased exploration ratio compared to irradiated (IRR alone) animals not given stem cells (Fig. 1C) . Again, similar trends were observed when total exploration of the novel spatial location (Fig. 1D) , as well as frequency of visits and latency to first explore the novel location, was analyzed (data not shown). These results suggest that hESC transplantation may also improve long-term retention of spatial information, although the treatment appeared to be more effective at the shorter, 5-min retention interval.
To analyze further why IRR animals showed impaired short-and long-term NPR behavior, total time spent exploring both objects during the familiarization phase given before the retention intervals was analyzed. IRR animals tended to spend less time exploring during the familiarization phase compared to both the control and IRR + hESC animals (Fig. 1E ). This result suggests that the impairments seen in the IRR animals at 5 min and 24 h postfamiliarization might be related to lower exploration during initial exposure to the objects.
Comparing Cognitive Outcomes Following Stem Cell Grafting
The foregoing results now provide the basis to make a comparison between hESC and hNSC transplantation for the restoration of cognition 1 and 4 months following irradiation. As indicated, IRR animals did not explore the novel spatial location more than expected by chance (dashed line) and showed significant deficits compared to nonirradiated controls (1-month, p = 0.001; 4-month, p = 0.014) (Fig. 2) following the 5-min retention interval. Animals transplanted with hESCs or hNSCs and tested on the NPR task at a 5-min retention interval 1 or 4 months later did not differ from nonirradiated controls at either postirradiation time and tended to explore the novel spatial location more than expected by chance (Fig. 2) . Transplantation of irradiated animals with human stem cells (IRR + hESC or IRR + hNSC) improved cognition significantly at 1 month when compared to their corresponding IRR group (Fig. 2) (p < 0.05). At 4 months postirradiation, stem cell-engrafted groups showed a trend toward improved cognition compared to nontransplanted animals tested 4 months postirradiation (Fig. 2) .
Stereological Enumeration of Engrafted Cell Survival
To establish the extent of engrafted cell survival at 1 and 4 months postirradiation, unbiased stereology was undertaken to quantify the yield of human cells in the host brain. Optical fractionator analysis of brain sections from the 1-and 4-month postengraftment group using BrdU immunostaining revealed that engrafted cells migrated extensively throughout the hippocampus, populating the dentate gyrus (DG), dentate hilus (DH), and CA3 and CA1 subfields and slightly into the corpus callosum (CC) (data not shown). Past work has shown that engrafted cells preferentially migrated to the dentate subgranular zone (SGZ), the neurogenic niche of the hippocampus, at both the 1-and 4-month postengraftment time points (2). Stereologic quantification of 1-and 4-month tissues revealed engrafted cell survival levels of 35% and 17%, Figure 2 . IRR-induced deficits in novel place recognition (NPR) performance are ameliorated in animals receiving hippocampal transplantation of human stem cells 1 and 4 months after irradiation. Irradiated animals did not explore the novel spatial location more than expected by chance (indicated by dashed line) and showed significant deficits compared to nonirradiated controls. By contrast, animals transplanted with either human embryonic (hESCs) or human neural (hNSCs) stem cells did not differ from nonirradiated controls on the 5-min test and tended to explore the novel spatial location more than chance. At 1 month, transplanted animals showed a significant improvement in NPR performance. Similar trends were observed 4 months post-IRR in both transplanted groups. Graphs show group means + 1 SEM. *Significant difference versus controls. #Significant difference versus corresponding IRR group (i.e., p < 0.05 on post hoc Fisher LSD group comparisons). respectively (Fig. 3) , whereas, for hNSCs, engrafted cell survival was 23% and 12.5%, respectively (3) (Fig. 3) . These relative yields of hESCs translated to an average of approximately 138,000 and 65,000 new cells added to each hemisphere at 1 and 4 months postengraftment, respectively. The average yield of new hNSCs added to each hippocampus at 1 and 4 months postengraftment were approximately 123,000 and 49,000, respectively (3). We did not observe any tumor formation at 1 and 4 months postgrafting with either human stem cells.
Phenotypic Fate of Engrafted hESCs
To elucidate the fate of engrafted cells, neuronal and glial markers were assessed in conjunction with BrdU labeling 1 and 4 months after grafting (Fig. 4A) . The expression of the functional cell cycle marker (Ki67) was 4% at 1 month and reduced to 2% at 4 months postgrafting (data not shown). By contrast, expression of the neural stem cell marker (nestin) remained steady (1.6-2%) at both postgrafting time points (data not shown). The yield of immature (BrdU + /Tuj1 + ) neurons dropped from 18% to 3% from 1 to 4 months postgrafting, while the yield of mature (BrdU + /NeuN + ) neurons was reduced from 8% to 4%, respectively, over this same time frame (Fig. 4B) . The majority of engrafted cells differentiated along astroglial line ages (Fig. 4A, B) . The yield of immature (BrdU + /GFAP + ) astrocytes increased from 14% to 23% from 1 to 4 months postgrafting, while the yield (7-8%) of mature (BrdU + / S100 + ) astrocytes did not differ at either time (Fig. 4B) . Although BrdU + /GFAP + engrafted cells were located throughout the hippocampus, astrocytic differentiation was most predominant in the CC (data not shown). The yield of oligo-progenitor (BrdU + /NG2 + ) cells increased from ~3% to 8% in the 1-to 4-month groups, respectively, while mature oligodendrocytes (BrdU + /O4 + ) showed little change in yield (8-9%) over these same times (Fig. 4B) .
Thus, 1 month after transplantation, 26% of engrafted cells differentiated into neurons and 31% differentiated into glia (Fig. 5A, B) . At 4 months, the relative yield of neurons dropped to 7%, while the yield of glia increased to 46% (Fig. 5A, B) . Absolute numbers of newly added neurons and glia per hippocampus were also calculated ( Fig. 5C, D) . Extrapolating these yields of differentiated cell types based on stereology estimates indicates that transplantation of hESCs resulted in the addition of approximately 36,000 neurons and 44,000 astroglia at 1 month postengraftment (Fig. 5C, D) , whereas approximately 4,700 neurons and 30,000 astroglia were added at 4 months postengraftment (Fig. 5C, D) into each hemisphere of irradiated animals.
DISCUSSION
The radiotherapeutic management of brain cancer adversely impacts quality of life in survivors due to the progressive and often debilitating cognitive decrements that develop over time. Our finding that intrahippocampal engraftment of human stem cells prevents the development of radiation-induced cognitive impairment suggests that stem cell replacement strategies might one day be a promising strategy for treating this serious adverse side effect. Our present and past data (2-5) clearly show the benefits of using transplanted stem cells for ameliorating radiation-induced cognitive deficits. Engraftment of either hESCs or hNSCs affords comparable benefits to cognition when analyzed at 1 or 4 months after grafting based on the NPR task (Fig. 2) . Unlike hESC-transplanted animals assessed 1 month posttransplantation, those assessed at the 4-month time point did not show statistically significant improvements in NPR performance compared to nontransplanted IRR animals (Fig. 2) . This is due to the fact that their performance was compared with IRR animals assessed 4 months after whole-brain irradiation, which showed less impaired performance compared to those assessed 1 month postirradiation, possibly because the protracted assessment time allowed for some amount of recovery. Further, although several independent studies have now shown the novel place recognition task to be sensitive to radiation-induced deficits as well as improvements following transplantation surgery, this behavioral test paradigm relies on spontaneous exploration, which may be confounded by group differences in locomotor activity or anxiety levels. We assessed locomotor activity (distance traveled and velocity of movement) in our experimental animals during the initial familiarization phase of the NPR task. Irradiated animals, whether they underwent transplantation surgery or not, showed reduced locomotion and velocity compared to nonirradiated controls (data not shown). Thus, additional paradigms that do not rely on spontaneous exploration but are known to engage the hippocampus, such as contextual fear conditioning and water maze spatial learning, are needed to confirm and extend the present findings. Further, important decisions regarding the best choice of cell types to use for similar such strategies must also rely on additional data and endpoints, such as longer-term efficacy and safety with regards to teratoma risk. While data indicate hNSCs provide slightly better cognitive benefits than hESCs based on exploration ratios measured, differences between these cell types for the restoration of cognition were not however found to be statistically significant.
Following irradiation and engraftment, stem cells survived and migrated extensively throughout the hippocampus, expressing neuronal and astrocytic markers (Fig. 4) . Engrafted hESC survival quantified by unbiased stereology revealed that 35% and 17% of the transplanted cells survived at 1 and 4 months, respectively. By contrast, our recent findings with hNSCs resulted in 23% and 12% of the transplanted cells remaining at these same time points (3). While absolute differences in the yield of surviving cells are to be expected between these cell types under the experimental conditions, it is interesting that the relative decrease in surviving cells from 1 to 4 months was nearly identical (i.e., ~2-fold reduction). Despite the drop in the number of engrafted cells, our data suggest that each stem cell type is subject to and sensitive to similar selective pressures for survival within the irradiated tissue bed.
Precisely how the attrition of engrafted cells impacts endogenous neurogenesis and cognition is unclear at this time. Cell death could cause disruptions to the neurovascular unit by altering the blood-brain barrier and neurovascular niche (34, 35, 38) . Alterations to the functional interaction between nonneuronal cells types in close proximity to neurons may modulate paracrine signaling and/or leave an inflammatory footprint for the recruitment and activation of microglia (35, 38) . Activated microglia increase following irradiation (20) and their role as pro-or antineurogenic affectors depend on the FACING COLUMN Figure 4 . Differentiation of transplanted hESCs in the irradiated hippocampus. Engrafted hESCs differentiated into neuronal and astroglial phenotypes at 1 and 4 months postengraftment. hNSC graft-derived BrdU + cells differentiated into neuronspecific class III b-tubulin + (Tuj1 + ) immature and neuronal nuclei + (NeuN + ) mature neurons (A, B) . The majority of engrafted hESCs differentiated into S100 + (S100b protein) mature and glial fibrillary acidic protein + (GFAP + ) immature astrocytes (A, B) and oligodendrocyte marker O4 + (O4 + ) mature and chondroitin sulfate proteoglycan 4 + (NG2 + ) oligo-progenitor cells. Arrows indicate dual-labeled engrafted cell. Scale bars: 5 µm (A). equilibrium between secreted molecules having proor anti-inflammatory properties (13). While the role of immune modulation in neurogenesis, learning, and memory in our irradiated animal model remains to be clarified, a wealth of evidence clearly suggests that these are important issues to resolve (7, 37) .
While improved cognition may track with the number of surviving cells (i.e., there was a trend of improved performance at 1 month compared to 4 months), the absolute number of engrafted cells surviving at the times of cognitive testing may have been more than necessary to ameliorate any radiation-induced cognitive decrements. On average, about 5,000 newly born cells are added to each hippocampus (hemisphere) per day, accounting for approximately 150,000 new cells per month (26). A cranial dose of 10 Gy depletes about 90% of newly born and proliferating cells, but not more mature neuronal phenotypes (20). Therefore, ~135,000 fewer cells will be added to the hippocampus as a result of the irradiation 1 month prior. Based on stereological estimates, about 140,000 engrafted cells (hESCs) survived 1 month after irradiation. Therefore, this number of engrafted cells compensates for the number of newly born cells that would have survived in the unirradiated brain.
It should also be noted that cognition is a complex and multifaceted end point and is likely to rely on many factors besides the yield of surviving engrafted cells. Nonetheless, quantifying the yields of surviving engrafted cells does provide useful information in defining cellular dose-response thresholds for the improvement of cognition after cranial irradiation. Clearly, the numbers and types of engrafted cells surviving at 1 and 4 months were sufficient to offset the adverse effects of radiation on NPR performance. Whether fewer cells would be equally efficacious is uncertain at this time. In the present study, quantification of phenotypic fate of the engrafted hESCs revealed the addition of both immature and mature neurons and astroglial cell types in the irradiated hippocampus 1 and 4 months afterward (Fig. 4) . The adverse impact of irradiation on cognition was effectively Figure 5 . yields of differentiated human stem cells engrafted in the irradiated brain. The phenotypic fate of hESCs and hNSCs expressed as a percentage in each hippocampus of the irradiated rat brain (A, B) . The yield of differentiated hESCs and hNSCs in each hippocampus of the irradiated rat brain as calculated from stereological estimates of graft-derived cells (C, D). #p < 0.002 and ##p < 0.001, significant difference between the 1-and 4-month postgrafting groups. *p < 0.05, **p < 0.01, and ***p < 0.001, significant difference between the hESC-and hNSC-engrafted groups. counteracted 1 month later by the presence of ~140,000 newly added cells (~26% neuronal and 31% glial), while at 4 months after irradiation, only ~65,000 newly added cells (7% neuronal and 46% glial) were required to prevent the cognitive deficits observed in irradiated rats receiving no engraftment. While the mechanism(s) of stem cell-based cognitive rescue has not been elucidated, it is likely that some combination of functional replacement and/or trophic support is playing a role.
Our past data showing that engrafted neurons express the activity-regulated cytoskeleton-associated protein Arc, a behaviorally induced immediate early gene in the CNS, suggests that cell replacement may provide certain benefits to cognition (3). Nonetheless, trophic support derived from the engrafted astroglial cells is likely to impact cognitive processes as well. Engrafted cells secrete a range of beneficial growth factors like glial-derived growth factor (GDNF) and brain-derived growth factor (BDNF) (9, 11, 18) . More recent data suggest that grafthost interactions can be facilitated by manipulations to the microvascular niche and maintenance of gap junctions (17, 24, 25) . Astrocytes are also known to modulate nucleoside metabolism, and changes in adenosine levels mediated by adenosine kinase may impact cognition through alterations in the bioenergetics of synaptic networks (10,12). Learning and activity increase the levels of basic fibroblast growth factor (bFGF), which in turn increases astrocyte densities in the hippocampus (16), and infusion of bFGF following traumatic brain injury increases neurogenesis and enhances cognitive recovery (33). Notwithstanding the importance of neurons, significant work has clearly defined critical roles for astrocytes in a wide spectrum of functions that support the integration of information necessary for learning and the consolidation of memory (15, 27) .
Collectively, our transplantation data indicate the broader applicability of using stem cell-based replacement strategies for the amelioration of radiation-induced cognitive deficits. Somewhat unexpectedly, significant differences between the differentiated fates of engrafted hESCs versus hNSCs were not found (Fig. 5 ). Each cell type was found to commit to roughly the same proportion of neuronal and astroglial lineages at each time postgrafting; the only real difference was found in the higher incidence of neuronal differentiation of the hESCs at the 1-month postgrafting time. These data suggest that both pluripotent and multipotent cells respond similarly to the same microenvironmental cues persisting in the irradiated host brain, where they survive and differentiate to ameliorate cognitive dysfunction over protracted times after irradiation. While additional studies regarding the persistence and safety of stem cell transplants are still required, the persistent benefits found from a single dose of stem cells in our present and past studies (2-5) suggest that this strategy may provide a satisfactory long-term solution to the cognitive deficits experienced by brain tumor survivors subjected to cranial radiotherapy.
